News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
855,197 Results
Type
Article (87042)
Company Profile (704)
Press Release (767438)
Multimedia
Podcasts (154)
Webinars (20)
Section
Business (232900)
Career Advice (4133)
Deals (39770)
Drug Delivery (131)
Drug Development (91146)
Employer Resources (200)
FDA (18214)
Job Trends (17374)
News (397010)
Policy (39855)
Tag
Academia (3002)
Academic (2)
Accelerated approval (15)
Adcomms (33)
Allergies (110)
Alliances (56978)
ALS (123)
Alzheimer's disease (1619)
Antibody-drug conjugate (ADC) (192)
Approvals (18177)
Artificial intelligence (420)
Autoimmune disease (39)
Automation (22)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (139)
Biotechnology (482)
Bladder cancer (109)
Brain cancer (44)
Breast cancer (413)
Cancer (3275)
Cardiovascular disease (263)
Career advice (3542)
Career pathing (34)
CAR-T (217)
CDC (43)
Cell therapy (600)
Cervical cancer (26)
Clinical research (74570)
Collaboration (1174)
Company closure (3)
Compensation (782)
Complete response letters (42)
COVID-19 (2917)
CRISPR (71)
C-suite (409)
Cystic fibrosis (125)
Data (3338)
Decentralized trials (2)
Denatured (55)
Depression (84)
Diabetes (390)
Diagnostics (7009)
Digital health (26)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (195)
Drug pricing (160)
Drug shortages (36)
Duchenne muscular dystrophy (167)
Earnings (98296)
Editorial (50)
Employer branding (25)
Employer resources (169)
Events (131721)
Executive appointments (931)
FDA (20244)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1052)
Gene editing (154)
Generative AI (42)
Gene therapy (470)
GLP-1 (959)
Government (5302)
Grass and pollen (7)
Guidances (312)
Healthcare (20921)
HIV (47)
Huntington's disease (32)
IgA nephropathy (48)
Immunology and inflammation (198)
Immuno-oncology (15)
Indications (43)
Infectious disease (3124)
Inflammatory bowel disease (168)
Inflation Reduction Act (13)
Influenza (80)
Intellectual property (135)
Interviews (813)
IPO (17909)
IRA (58)
Job creations (5194)
Job search strategy (2863)
Kidney cancer (15)
Labor market (63)
Layoffs (608)
Leadership (27)
Legal (10139)
Liver cancer (87)
Longevity (12)
Lung cancer (455)
Lymphoma (230)
Machine learning (16)
Management (65)
Manufacturing (494)
MASH (106)
Medical device (14766)
Medtech (14776)
Mergers & acquisitions (22632)
Metabolic disorders (996)
Multiple sclerosis (107)
NASH (23)
Neurodegenerative disease (166)
Neuropsychiatric disorders (48)
Neuroscience (2430)
NextGen: Class of 2025 (7687)
Non-profit (5091)
Now hiring (51)
Obesity (505)
Opinion (296)
Ovarian cancer (108)
Pain (132)
Pancreatic cancer (136)
Parkinson's disease (207)
Partnered (26)
Patents (348)
Patient recruitment (200)
Peanut (55)
People (65850)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23002)
Phase II (32372)
Phase III (24387)
Pipeline (2069)
Policy (260)
Postmarket research (3554)
Preclinical (10392)
Press Release (72)
Prostate cancer (159)
Psychedelics (46)
Radiopharmaceuticals (279)
Rare diseases (551)
Real estate (7402)
Recruiting (76)
Regulatory (27390)
Reports (63)
Research institute (2667)
Resumes & cover letters (650)
Rett syndrome (10)
RNA editing (13)
RSV (62)
Schizophrenia (110)
Series A (175)
Series B (125)
Service/supplier (30)
Sickle cell disease (69)
Special edition (22)
Spinal muscular atrophy (168)
Sponsored (38)
Startups (4309)
State (2)
Stomach cancer (17)
Supply chain (86)
Tariffs (75)
The Weekly (97)
Vaccines (954)
Venture capital (62)
Weight loss (343)
Women's health (53)
Worklife (20)
Date
Today (169)
Last 7 days (827)
Last 30 days (2482)
Last 365 days (33836)
2025 (20736)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (73)
Alaska (7)
Arizona (283)
Arkansas (14)
Asia (50634)
Australia (8896)
California (8283)
Canada (2533)
China (760)
Colorado (353)
Connecticut (369)
Delaware (222)
Europe (116246)
Florida (1237)
Georgia (280)
Hawaii (3)
Idaho (67)
Illinois (764)
India (35)
Indiana (406)
Iowa (19)
Japan (250)
Kansas (118)
Kentucky (34)
Louisiana (20)
Maine (74)
Maryland (1162)
Massachusetts (6314)
Michigan (283)
Minnesota (516)
Mississippi (4)
Missouri (109)
Montana (32)
Nebraska (26)
Nevada (89)
New Hampshire (74)
New Jersey (2303)
New Mexico (31)
New York (2284)
North Carolina (1292)
North Dakota (10)
Northern California (3619)
Ohio (265)
Oklahoma (17)
Oregon (48)
Pennsylvania (1764)
Puerto Rico (18)
Rhode Island (41)
South America (1654)
South Carolina (38)
South Dakota (1)
Southern California (3107)
Tennessee (136)
Texas (1266)
United States (31054)
Utah (242)
Virginia (224)
Washington D.C. (80)
Washington State (719)
West Virginia (4)
Wisconsin (89)
There are 855,197 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Neuregen’s first-in-class in situ trans-differentiation therapy for glioblastoma received IND Clearance from the FDA
August 12, 2025
·
1 min read
Government
Top ARPA-H Official Departs in Protest of BARDA mRNA Cuts
Alastair Thomson, chief data officer at the HHS sub-agency, announced his resignation in opposition to Health Secretary Robert F. Kennedy Jr.'s “stupid” decision to cancel $500 million worth of contracts focused on mRNA technology.
August 12, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
Bayer and Kumquat Biosciences enter global exclusive license and collaboration in precision oncology
August 12, 2025
·
6 min read
Press Releases
IGC Pharma Highlights Alzheimer’s Pipeline with Encouraging Preclinical Data on IGC-M3 and Advancing Phase 2 Cannabinoid-Based IGC-AD1
August 12, 2025
·
5 min read
Press Releases
Marea Therapeutics Enrolls First Participant in Phase 1 Clinical Study Evaluating MAR002 for Acromegaly
August 12, 2025
·
3 min read
Press Releases
Agendia Announces Publication in JNCI Cancer Spectrum Demonstrating that MammaPrint® Predicts Chemotherapy Benefit in HR+HER2- Early Breast Cancer Using Real-World Evidence from the FLEX Study
August 12, 2025
·
4 min read
Press Releases
Following FDA Announcement, Teal Health’s Teal Wand™ for At-Home Cervical Cancer Screening is Now Available, Starting in California
August 12, 2025
·
4 min read
Press Releases
FDA Approves BRINSUPRI™ (brensocatib) as the First and Only Treatment for Non-Cystic Fibrosis Bronchiectasis, a Serious, Chronic Lung Disease
August 12, 2025
·
15 min read
Press Releases
Techcyte and Modella AI Announce a Research Collaboration with Modella AI’s State-of-the-Art Agentic and Generative AI-Powered Diagnostic Pathology Platform
August 12, 2025
·
3 min read
Press Releases
pH-D Feminine Health Launches First FDA-Cleared Phase 3 Clinical Trial for Boric Acid Suppositories
August 12, 2025
·
2 min read
1 of 85,520
Next
